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AP-1cFos/JunB/miR-200a regulate the
pro-regenerative glial cell response during
axolotl spinal cord regeneration
Keith Z. Sabin1,3, Peng Jiang2, Micah D. Gearhart1, Ron Stewart2 & Karen Echeverri1,3
Salamanders have the remarkable ability to functionally regenerate after spinal cord trans-
ection. In response to injury, GFAP+ glial cells in the axolotl spinal cord proliferate and
migrate to replace the missing neural tube and create a permissive environment for axon
regeneration. Molecular pathways that regulate the pro-regenerative axolotl glial cell
response are poorly understood. Here we show axolotl glial cells up-regulate AP-1cFos/JunB
after injury, which promotes a pro-regenerative glial cell response. Injury induced upregu-
lation of miR-200a in glial cells supresses c-Jun expression in these cells. Inhibition of miR-
200a during regeneration causes defects in axonal regrowth and transcriptomic analysis
revealed that miR-200a inhibition leads to differential regulation of genes involved with
reactive gliosis, the glial scar, extracellular matrix remodeling and axon guidance. This work
identiﬁes a unique role for miR-200a in inhibiting reactive gliosis in axolotl glial cells during
spinal cord regeneration.
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Salamanders have retained the remarkable ability to func-tionally regenerate after spinal cord injury (SCI)1–9. Inresponse to SCI, glial ﬁbrillary acidic protein (GFAP)+ glial
cells proliferate and migrate through the lesion to create a per-
missive environment for axon regeneration9–12. This is in stark
contrast to the mammalian response to SCI where damaged
astrocytes undergo reactive gliosis and contribute to the glial scar
by secreting axon growth inhibitory proteins like chondroitin
sulfate proteoglycans (CSPGs) and collagens13–16. The glial scar is
a complex subject, it has been shown to be beneﬁcial by pre-
venting more damage to the spinal cord but it also expresses
proteins that are inhibitory to axon regeneration16. Many dif-
ferent vertebrate animals, in addition to salamanders; have the
ability to regenerate a functional spinal cord after injury,
including lamprey, xenopus and zebraﬁsh. Common to all these
animals is that regeneration occurs in the absence of reactive
gliosis and glial scar formation10–12,17. The molecular pathways
that promote functional spinal cord regeneration without glial
scar formation are poorly understood.
Recent advances in molecular genetics and transcriptional
proﬁling techniques are beginning to elucidate the molecular and
cellular responses necessary for functional spinal cord regenera-
tion. Lampreys, which represent the most basal vertebrate
ancestor that diverged from a shared common ancestor to
humans more than 560 million years ago, can regenerate loco-
motive function within 12 weeks of a full spinal cord transection.
After SCI in lamprey resident GFAP+ astrocytes elongate and
form a glial bridge that facilitates axons to regenerate through the
lesion18–26. This is reminiscent of the injury-induced glial bridge
formed by GFAP+ glial cells in zebraﬁsh spinal cord, which is
similarly necessary for axon regeneration27,28. Xenopus display
robust functional spinal cord regeneration in the larval stages by
activating the GFAP+/Sox2+ glial cells to divide, migrate, and
repair the lesion which allows axons to regenerate. However the
tadpoles ability to regenerate is lost after metamorphoses into an
adult frog29–41. Similar events occur in axolotl, GFAP+ /Sox2+
cells adjacent to the injury site are activated in response to injury
and will migrate to repair the lesion, however axolotls can
regenerate throughout life4,7–10,42. In axolotls an injury to the
spinal cord is fully repaired, rostral and caudal sides of the spinal
cord reconnect but there is no glial bridge structure formed as is
seen in zebraﬁsh43. A common theme in these species is the
absence of reactive gliosis and the lack of a glial scar. To facilitate
functional recovery these remarkable animals activate glial cells to
regenerate the ependymal tube or form a glial bridge both of
which act as a highway to guide axon regeneration through the
lesion site.
In contrast mammalian glial cells; often referred to as astro-
cytes; undergo a process of reactive gliosis in response to
injury. Historically, reactive astrocytes were characterized
as highly proliferative, hypertrophic cells that express high
levels of GFAP. Advances in lineage tracing and transcriptomic
proﬁling approaches have revealed a much higher degree
of heterogeneity among reactive astrocytes44,45. Recent pub-
lications suggest that reactive astrocytes and components of
glial scar are beneﬁcial for mitigating the inﬂammatory
response, resulting in less neuronal death early after injury46–48.
However, the chronic persistence of the glial scar remains a
major barrier to axon regeneration. Despite the high degree
of heterogeneity across reactive astrocytes, several injury
models have identiﬁed a critical role for the transcriptional
complex AP-1 in promoting reactive gliosis by activating the
GFAP promoter and other downstream pathways leading to
glial scar formation49–54.
AP-1 is commonly formed as a heterodimeric complex of FOS
and JUN proteins capable of regulating the expression of various
genes involved with cell cycle, extracellular matrix remodeling
and cell migration55–58. Research from several labs has shown
that while Jun family members can homodimerize; c-Fos is an
obligate heterodimer59–62. The identity of AP-1 target genes and
the ability of AP-1 to transcriptionally activate or repress target
genes is partially dependent on the combination of FOS and JUN
proteins that comprise the AP-1 dimer57,63–65. Interestingly, after
CNS injury in mammals both c-Fos and c-Jun are upregulated in
reactive astrocytes and function to promote reactive gliosis and
glial scar formation49–51,66. After SCI, axolotl glial cells upregu-
late expression of c-Fos, Fos protein is found in cells adjacent to
the injury site for 1 day post injury. Inhibition of c-Fos expression
leads to defects in spinal cord regeneration11. Additionally,
inhibition of Jun N-terminal kinase (JNK) blocks spinal cord
regeneration in axolotl11. Unlike mammals, these results highlight
an important, pro-regenerative role for AP-1 during axolotl
spinal cord regeneration. However in axolotl the identity of the
c-Fos binding partner was unknown.
Here we identify that axolotl glial cells express a non-canonical
AP-1cFos/JunB after SCI. Axolotl glial cells up-regulate miR-200a
expression, which directly represses c-Jun expression during
spinal cord regeneration, thereby blocking the formation of AP-
1cFos/cJun. Furthermore, chronic overexpression of AP-1cFos/cJun
in axolotl glial cells leads to defects in axon regeneration. Speciﬁc
inhibition of miR-200a in axolotl glial cells partially phenocopied
AP-1cFos/cJun overexpression leading to defects in axon regen-
eration. Transcriptomic proﬁling of control or miR-200a inhi-
bitor electroporated spinal cords identiﬁed differential expression
of genes indicative of reactive gliosis and glial scar formation.
Our data support a role for the non-canonical AP-1cFos/JunB in
promoting the pro-regenerative glial cell response necessary for
spinal cord regeneration in axolotl.
Results
Glial cells up-regulate the non-canonical AP-1cFos/JunB. We
have previously shown that the transcription factor c-Fos is
upregulated in GFAP+ glial cells in axolotl 1 day post SCI and is
necessary for glial cell division after injury11. However, c-Fos
functions as an obligate heterodimer but the identity of the c-Fos-
binding partner in axolotl glial cells was unknown11. To deter-
mine if the canonical AP-1cFos/cJun is expressed in axolotl glial
cells, we performed immunoﬂuorescent staining for c-Jun at 1 day
post injury in axolotl spinal cords. This analysis revealed that c-
Jun is not upregulated in GFAP+ glial cells after injury but is
strongly expressed in NeuN+ neurons (Fig. 1a). This suggests that
axolotl glial cells do not up-regulate the canonical AP-1cFos/cJun
after injury but instead must up-regulate a different JUN family
member.
To discover putative c-Fos-binding partners, we mined
previously published transcriptional proﬁling data of axolotl
spinal cord regeneration11. This approach identiﬁed JunB as a
potential c-Fos-binding partner due to its similar transcriptional
dynamics after SCI. Subsequent qRT-PCR conﬁrmed that JunB is
upregulated after SCI, which mirrors the expression dynamics of
c-Fos (Fig. 1c). In situ hybridization conﬁrmed that JunB is
expressed in glial cells, which line the central canal at 1 day post
injury, these cells are easily identiﬁable due to their oval shape
and position (Fig. 1b schematic, 1d JunB staining). Finally, to
conﬁrm that axolotl c-Fos and JunB interact biochemically we
utilized the biotin based BioID system67. Axolotl JunB-BioID
showed robust c-Fos pull down, conﬁrming their speciﬁc
biochemical interaction (Supplementary Figure 1A). Taken
together, these results support our hypothesis that after SCI,
axolotl glial cells primarily form the non-canonical AP-1cFos/JunB
heterodimer.
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Differential activity of AP-1 complexes at the GFAP promoter.
After SCI in mammals, damaged mammalian astrocytes become
reactive, upregulate GFAP expression and contribute to glial scar
formation15,16. Previous work in axolotl suggests that after spinal
cord injury GFAP+ glial cells in fact downregulate many inter-
mediate ﬁlament proteins including GFAP68. We used qRT-PCR
to assay GFAP expression during axolotl spinal cord regeneration
and conﬁrmed that in our transection model GFAP levels are
downregulated after injury (Fig. 2a). These results suggest that
axolotl glial cells undergo a fundamentally different molecular
response to injury than mammalian astrocytes. Interestingly, AP-
1cFos/cJun directly regulates GFAP expression during reactive
gliosis in mammals51. Therefore, we wanted to test if a different
composition of the AP-1 complex can lead to differential GFAP
promoter activity.
We cloned a fragment of axolotl GFAP promoter, that is the
equivalent region of the human promoter which is sufﬁcient to
drive GFP expression speciﬁcally in axolotl glial cells11,69. We
cloned this axolotl GFAP promoter upstream of a luciferase
reporter and co-transfected neural progenitor cells with axolotl
AP-1cFos/cJun or axolotl AP-1cFos/JunB. As expected, the canonical
AP-1cFos/cJun is a strong transcriptional activator of the GFAP
promoter (Fig. 2b). Interestingly as we hypothesized AP-1cFos/
JunB, actively repressed the axolotl GFAP promoter in the
luciferase assay (Fig. 2b). Taken together, these results suggest
that non-canonical AP-1cFos/JunB may function to mitigate
reactive gliosis and glial scar formation in axolotl glial.
Finally, we wanted to determine if chronic over expression of
AP-1cFos/cJun in axolotl glial cells is sufﬁcient to affect axolotl
spinal cord regeneration. Electroporation was used to introduce
GFP-tagged c-Fos and c-Jun overexpression constructs into the
glial cells of the spinal cord70. After 24 h, animals were screened
for GFP+ glial cells and animals with > 70% labeled glial cells
were selected for SCI. The animals were harvested 7 days post
injury, a time point at which axons have regenerated though the
lesion10,11, and the extent of axon regeneration was examined by
whole mount immunoﬂuoresence for β-III tubulin. In control
spinal cords, the β-III tubulin+ axons had regenerated through
the lesion as indicated by the yellow rectangle (Fig. 2c).
Conversely, when AP-1cFos/cJun was overexpressed in the glial
cells, this lead to defective axon regeneration, some axons
sprouted randomly and did not grow directly through the lesion
site, as indicated by the yellow box (Fig. 2d). This phenotype
could be indicative of an overall growth repulsive environment10
that may be reminiscent of the mammalian glial scar. The
phenotype observed is not a complete inhibition of axonal
regeneration and could be due to a competition between the
endogenous JunB and the overexpressed c-Jun for binding to
the endogenous c-Fos. This would result in some glial cells being
led to a pro-regenerative fate while others are directed towards
a less regenerative direction due to the presence of the c-Fos:c-
Jun heterodimer.
miR-200a represses c-Jun expression in axolotl glial cells. Our
previous work showed that c-Jun is highly upregulated in NeuN+
neurons and in dorsal root ganglia close to the injury site but is
not upregulated after injury in glial cells (Fig. 1a)42. Work from
our lab and many others have shown that dynamic regulation of
target gene expression by microRNAs (miRNA) is critical for
functional tissue regeneration10,71–76. Therefore, we wanted to
test the hypothesis that axolotl glial cells repress c-Jun expression
via a miRNA mediated mechanism. Analysis of the c-Jun
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Fig. 1 Axolotl glial cells express AP-1cFos/JunB after spinal cord injury. a Immunohistochemical analysis of regenerating spinal cords at 1 day post injury
shows only NeuN+ neurons express c-Jun. GFAP+ glial cells are negative for c-Jun expression (n= 5) Scale bars= 50 μm. b Schematic diagram of the
structure of the axolotl spinal cord, neuronal cell bodies that surround the glial cells are shown in blue, glial cells line the central canal (CC), they have a
large nucleus and express GFAP on the membrane (green). c qRT-PCR proﬁling shows upregulation of c-Fos and JunB during axolotl spinal cord
regeneration (n= 3). d In situ hybridization conﬁrms JunB expression in glial cells at 1 day post injury, higher magniﬁcation image of panel d, showing JunB
transcript in the oval-shaped glial cells that line the central canal (n= 5) Scale bars= 50 μm. ***p≤ 0.001. Error bars represent ± S.T.D
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3’ untranslated region (UTR) using TargetScan identiﬁed a con-
served miR-200 seed sequence across many species, including
axolotl. While miR-200 family members are known to play a
pivotal role during neurodevelopment77, little is known about
their function during regeneration.
A time course analysis revealed that miR-200a is expressed at
homeostatic levels in the uninjured spinal cord and is signiﬁcantly
upregulated at 3 days post injury (Fig. 3a). In situ hybridization
conﬁrmed that miR-200a is speciﬁcally expressed in glial cells
during axolotl spinal cord regeneration (Fig. 3b), panel 3b shows
a higher magniﬁcation image of the spinal cord, miR-200a is
expressed in the oval glial cells lining the central canal. To
determine whether miR-200a function is necessary for functional
spinal cord regeneration we injected and electroporated spinal
cords with a commercially available chemically synthesized miR-
200a inhibitor that knocked down miR-200a levels but did not
affect a closely related family member, miR-200b (Fig. 3c, d).
Whole mount β-III tubulin staining revealed miR-200a inhibition
resulted in a complete failure of axons to regenerate through the
lesion by 7 days post injury compared to controls (Fig. 3e, f).
Furthermore, axons were observed sprouting from the spinal cord
both rostral and caudal to the lesion, similar to regeneration
defects observed with AP-1cFos/cJun over expression (Fig. 2d).
Histological analysis of the control versus inhibitor treated
animals also revealed a failure of the rostral and caudal sides of
the spinal cord to reconnect (Supplementary Figure 2). This
failure of reconnection, which is necessary to facilitate growth of
axons through the lesion site may be due to perturbation in
proliferation of the GFAP+ glial cells after injury. Proliferation of
the glial cells 500 µm rostral and caudal to the injury site was
quantiﬁed by counting the number of GFAP+/EdU+ cells at
4 days post injury. This analysis revealed that even in the
uninjured spinal cord there is a small population of proliferative
glial cells (Fig. 4a, d) which signiﬁcantly increased by 4 days post
injury in control spinal cords (Fig. 4b, d) Inhibition of miR-200a
led to a signiﬁcant decrease in proliferation of glial cells after
injury (Fig. 4c, d). In axolotl it is known that reconnection of the
rostral and caudal sides of the neural tube is necessary for the
axons to regrow through the injury site2,8,9,42.
To determine whether c-Jun expression is affected by miR-200a
inhibition we assayed for changes in c-Jun transcript abundance
with qRT-PCR at 3 days post injury, the time point miR-200a is
most highly expressed (Fig. 3a), and found an increase in c-Jun
expression compared to control and uninjured spinal cords (Fig. 5a).
In addition inhibition of miR-200a in an uninjured spinal cord also
causes a signiﬁcant increase in c-Jun expression (Supplementary
Figure 1B). Interestingly, subsequent analysis showed that miR-200a
inhibition speciﬁcally lead to an upregulation of c-Jun protein in
GFAP+ glial cells (Fig. 5b). A small but insigniﬁcant number of
GFAP+ glial cells express a low level of c-Jun (Fig. 5b, c), however,
after inhibition of miR-200a there is a signiﬁcant increase in the
number of GFAP+ cells that express c-Jun at the protein level (Fig.
5b, c). Luciferase reporter experiments conﬁrmed that the axolotl c-
Jun 3′-UTR is directly targeted by miR-200a (Fig. 5d) and mutation
of the miR-200a seed sequence alleviates that repression (Fig. 5d).
Collectively, these experiments conﬁrm that miR-200a represses c-
Jun expression in GFAP+ glial cells.
miR-200a inhibition affects glial scar related genes. MicroRNAs
are able to regulate expression of dozens, if not hundreds, of
genes in multiple pathways to precisely coordinate various cel-
lular processes78. To gain a more comprehensive picture of the
role of miR-200a in regulating the pro-regenerative glial cell
response during axolotl spinal cord regeneration we performed
RNA sequencing analysis. Uninjured, control and miR-200a
inhibitor electroporated spinal cords were isolated at 4 days post
injury, one day after peak miR-200a upregulation and processed
for RNA sequencing (Fig. 3a).
Analysis of the RNA sequencing data compared the expression
proﬁles at 4 days post injury of control or miR-200a inhibitor
treated spinal cords to uninjured spinal cords was carried out
(Supplementary Data 1). From these comparisons genes that had
fold change in expression greater than 2.0-fold and a signiﬁcant
p-value (p ≤ 0.05) in one or both comparisons were included in
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Fig. 2 AP-1cFos/JunB differentially regulates GFAP expression. a qRT-PCR data showing down regulation of GFAP throughout the time course of spinal cord
regeneration (n= 4). b Luciferase reporter experiments carried out in a neural progenitor cell line, B35 cells, show different activation levels of the axolotl
GFAP promoter depending on the AP-1 complex present. Axolotl AP-1cFos/JunB represses the axolotl GFAP promoter, while AP-1cFos/cJun activates the
GFAP promoter (n= 3). c, d Whole mount antibody staining of β-III tubulin, overexpression of axolotl AP-1cFos/cJun inhibits axon regeneration at 7 days
post injury (d) compared to control injured animals (c). Yellow box indicates the area of injury (control n= 11, AP-1cFos/cJun OE n= 13). *p≤ 0.05,
**p≤ 0.01, ***p≤ 0.001. Error bars represent ± S.T.D. Scale bar= 75 μm
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further analysis. This approach identiﬁed a cohort of genes that
were differentially regulated at 4 days post injury after miR-200a
inhibition (Fig. 6a, Supplementary Data 1). A cohort of 462 genes
were identiﬁed with a greater fold change in the miR-200a
inhibitor samples. (δlog2FC > 1). While 153 genes were found to
be downregulated in the miR-200a inhibitor treated samples
(δlog2FC < -1) (Supplementary Figure 3). From research in
mammals a subset of these genes (Fig. 6) are known to be
involved with reactive gliosis and glial scar formation (LGALS1,
DCN, BCAN, TLR2, CSPG5) and have functions related to
extracellular matrix (COL21A1, CNTN1, FN1) and ECM
remodeling (ADAM23, LOXL1, HYAL4, MMP2, SERPINE1) as
well as cell migration (ITGBL1, ITGAD, CD151 ITGB1BP1,
ITGB3BP), axon migration (CHL1, CLSTN1, NEFM/H) and
inﬂammation (TLR2, CCL3L3, TNFAIP2)79–87. These data
collectively suggest that miR-200a inhibition is sufﬁcient to
disrupt expression of genes involved with multiple cellular
processes necessary for regeneration.
We used qRT-PCR analysis to conﬁrm and analyze more
carefully a subset of genes well documented to be involved with
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Fig. 3 Upregulation of miR-200a in glial cells after spinal cord injury is required for spinal cord regeneration. a qRT-PCR analysis shows that miR-200a is
upregulated at 3 days post injury (n= 3). b In situ hybridization conﬁrms miR-200a expression speciﬁcally in glial cells at 3 days post injury in the
regenerating spinal cord. The adjacent panel is a higher magniﬁcation of just the spinal cord from panel b, showing miR-200a expression in the oval shaped
glial cells that line the central canal (n= 6). Scale Bar= 50 μm. c qRT-PCR analysis conﬁrms knockdown of miR-200a after spinal cords were injected with
a miR-200a inhibitor (n= 3). d miR-200a inhibition does not affect miR-200b levels (n= 3). e Whole mount β-III tubulin staining at 7 days post injury in
control animals shows regeneration of axons through the lesion. f Inhibition of miR-200a results in defects in axon regeneration through the injury site in
comparison to control animals. Yellow box indicates the injury site, (controls n= 33, miR-200a inhibitor n= 35). *p≤ 0.05, **p≤ 0.01, ***p≤ 0.001, N.S. is
not signiﬁcant. Error bars represent ± S.T.D. Scale Bar= 75 μm
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reactive gliosis and glial scar formation. This conﬁrmed that miR-
200a inhibition leads to a highly signiﬁcant increase in vimentin
expression and a small but signiﬁcant increase in GFAP
expression (Fig. 6b) compared to 4 days post injury control
spinal cords. Remarkably, expression of the chondroitin sulfate
proteoglycan, CSPG4, which is consistently seen to be upregu-
lated after spinal cord injury in mammals88–90, is speciﬁcally
upregulated after miR-200a inhibition (Fig. 6b). In situ
hybridization was used to further validate the qRT-PCR data,
both vimentin and CSPG4 were found to be robustly expressed in
glial cells in animals treated with miR-200 inhibitor in
comparison to control animals (Supplementary Figure 4A, B).
These data suggest that inhibition of miR-200a after injury leads
to a more reactive phenotype and an overall more axon growth
inhibitory microenvironment similar to what is observed in
mammalian astrocytes after SCI.
Discussion
The present study has identiﬁed an important role for the non-
canonical AP-1cFos/JunB and miR-200a in regulating the pro-
regenerative glial cell response to SCI in axolotl (Fig. 7). Our
previous work has shown that upregulation of c-Fos in glial cells
is essential for proliferation of the glial cells and subsequent axon
regeneration42. Unlike JUN proteins, which can homodimerize to
form AP-1, c-Fos functions as an obligate FOS:JUN heterodimer
however the identity of the c-Fos binding partner in axolotl glial
cells was unclear60,91–93.
Immunoﬂuorescence analysis showed that c-Jun is upregulated
in NeuN+ neurons but not in GFAP+ glial cells after injury to the
spinal cord (Fig. 1a). Therefore, pro-regenerative glial cells do not
express high levels of the canonical AP-1cFos/cJun during axolotl
spinal cord regeneration. Interestingly, the JUN family member
JunB was instead upregulated and heterodimerizes with c-Fos in
axolotl glial cells (Fig. 1b, c, Supplementary Figure 1A). Studies
from mammalian CNS injury models have shown that the
canonical AP-1cFos/cJun heterodimer is upregulated and promotes
reactive gliosis and glial scar formation. Remarkably, mimicking
the mammalian situation by ectopically overexpressing AP-1cFos/
cJun in axolotl glial cells led to defects in axon regeneration,
indicative of an overall growth inhibitory environment, which
could be similar to the glial scar in mammals (Fig. 2d). However,
we do note that a small portion of axolotl GFAP glial cells do in
fact express c-Jun, these could be cells that are on their way to
becoming neurons, as it is known GFAP+ glial cells have the
potential to differentiate into both glial cells and neurons after
injury69,70.
In other vertebrates that have the ability to regenerate a
functional spinal cord Fos and Jun family members are also
differentially regulated after injury. In zebraﬁsh, similar to the
axolotl, c-Fos and JunB are upregulated 1 day post injury94.
In addition, lamprey upregulate c-Fos and JunD within 6 h of
injury while c-Jun is upregulated 3 days post injury. It is unclear
from these data if JunB is upregulated early or if lamprey
use JunD instead of JunB21. In the future, it will be interesting
to look across species to identify how this complex has evolved
in regeneration competent versus regeneration incompetent
organisms.
AP-1 is capable of regulating expression of many genes
involved with cellular proliferation, migration, cell survival,
apoptosis, extracellular matrix and ECM remodeling. Some of
these processes are mutually exclusive (i.e., cell survival and
apoptosis) and the ability of AP-1 to speciﬁcally regulate a
subset of genes is highly context dependent58,64,95. One factor
contributing to the ability of AP-1 to regulate target genes is
the combination of FOS and JUN proteins that comprise
the heterodimer. Additionally, the composition of AP-1 can
partially affect its ability to act as a transcriptional activator
or repressor. For example, AP-1FosB/JunB transcriptionally acti-
vates FoxD5b expression during Xenopus neural development
while AP-1cFos/cJun acts as a transcriptional repressor96. Fur-
thermore, JunB can antagonize the ability of c-Jun to transform
non-malignant cells97. Indeed, often times JunB and c-Jun sig-
naling directly antagonize one another57,98. These observations
are consistent with our ﬁndings that the canonical AP-1cFos/cJun
is a potent transcriptional activator of the axolotl GFAP promoter
while AP-1cFos/JunB represses the axolotl GFAP promoter
(Fig. 2b).
These experiments highlight the possibility that differential
combination of AP-1 subunits could induce very different cellular
response to injury. While our luciferase assays show AP-1cFos/JunB
does not fully repress luciferase activity compared to the control it
is important to realize that while GFAP expression is down-
regulated during axolotl spinal cord regeneration (Fig. 2a) there is
still a basal level of GFAP expression suggesting homeostatic
levels of promoter activity. Additionally, GFAP expression is
controlled by multiple transcription factors including NF-κB and
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STAT3 therefore it is not surprising that AP-1cFos/JunB does not
fully repress the GFAP promoter alone99. In the future it will be
interesting to identify other factors that synergize with AP-1cFos/
JunB to regulate the pro-regenerative glial cell response. Indeed,
co-occupancy of AP-1 with key pioneering transcription factors is
necessary for efﬁcient chromatin remodeling highlighting a pos-
sible role for AP-1cFos/JunB in aiding to remodel the chromatin
landscape to a more permissive environment to allow for later
waves of gene expression that promote the pro-regenerative glial
cell response100,101.
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Our data support a model where pro-regenerative glial cells
upregulate AP-1cFos/JunB; however, the mechanism by which
c-Jun expression is repressed was not clear. Our lab and others
have shown that microRNAs play a critical role in ﬁne-tuning the
genetic programs necessary for tissue regeneration10,71–76. We
have identiﬁed miR-200a as a microRNA that regulates levels of
c-Jun expression in GFAP+ glial cell in axolotl. miR-200a is
speciﬁcally expressed in glial cells adjacent to the central canal
and is differentially expressed during spinal cord regeneration
(Fig. 3a, b). Importantly, inhibition of miR-200a led to an
increase in c-Jun transcript abundance and co-expression of c-Jun
in GFAP+ glial cells (Fig. 4). MicroRNA mediated repression
does work in a binary fashion, which explains why GFAP+ glial
cells in homeostatic conditions do in fact express a low basal level
of c-Jun. However it is the upregulation of miR-200a and sub-
sequent repression of c-Jun that is essential to ensure that the
levels of the c-Jun protein are kept low, which facilitates a pre-
ferential heterodimerization event to occur between the upregu-
lated JunB and c-Fos after injury to the spinal cord. Inhibition of
miR-200a blocks spinal cord regeneration (Fig. 3d, Supplemen-
tary Figure 2) similar to the phenotype observed with AP-1cFos/
cJun overexpression (Fig. 2d). However, miR-200a inhibition
resulted in a more severe phenotype than overexpression of
AP-1cFos/cJun, this may be due to technical reasons. The efﬁcacy
of introducing a small molecule inhibitor into the glial cells is far
higher than the efﬁcacy of overexpressing two plasmids in these
cells. In addition, when we overexpress c-Jun in the glial cells
it must compete with the endogenous JunB for binding to c-Fos
and hence may result in a less severe phenotype. This does not
rule out the possibility that other downstream targets of miR-
200a are also affected and are necessary for functional spinal
cord regeneration.
In this study, we used chemically synthesized inhibitors to
knock down miR-200a levels rather than using a knockout
strategy like CRISPR which has been shown to work effectively in
axolotl102,103. In the future, it will be interesting to determine if a
conditional CRISPR knockout of miR-200a in glial cells leads to
complete block of regeneration, however the technology is not yet
available in axolotl to carry out this experiment. There are several
reasons for choosing a knockdown approach, other studies in
zebraﬁsh have shown that, in some cases, knockouts do not give a
phenotype due to compensation by other related genes and this
could easily occur with microRNA genes as there are several very
similar family members104. More recent work in mouse ES cells
and human cells has identiﬁed large deletions and complex
rearrangement of genomic information as a result of gene knock-
out using CRISPR technology105. These bodies of work suggest
that a less severe knockdown strategy may in fact reveal more
about the underlying biology especially in relation to regeneration
where we want the genes to be present during development and
only interfere with their function during the regeneration process.
While we have identiﬁed c-Jun as one miR-200a target, miR-
NA’s are able to target dozens if not hundreds of genes to
orchestrate multiple cellular pathways. Therefore we performed
RNA sequencing of spinal cord tissue from uninjured spinal
cords and regenerating spinal cords microdissected from 500
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Fig. 7 Model of the potential role of AP-1 and miR-200a in spinal cord regeneration. a After SCI, axolotl glial cells up-regulate expression of AP-1cFos/JunB,
which functions to repress GFAP expression and to regulate downstream pathways that direct glial cells to divide, migrate and functionally repair the
missing spinal cord tissue. Additionally, miR-200a is upregulated which represses c-Jun expression thereby blocking formation of the canonical
AP-1cFos/cJun. b Inhibition of miR-200a during spinal cord regeneration results in higher levels of GFAP expression, ectopic expression of c-Jun in GFAP+
glial cells, upregulation of genes indicative of a glial scar like environment and a failure in axon regeneration
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micrometers rostral and 300 micrometers caudal to the lesion.
This area corresponds to the area from which glial cells contribute
to regeneration42. While this method does not speciﬁcally isolate
only the glial cells it allows us to identify gene expression changes
resulting from non-cell autonomous affects of miR-200a inhibi-
tion and facilitate the identiﬁcation of molecules that could
contribute to the lesion microenvironment. We cannot rule out
that mRNA present in the severed axons also contributes to the
RNA sequencing data set and in fact the potential role of mRNAs
from axons in regeneration may be very important to investigate
in future studies. However no genes speciﬁc to muscle or
skin were identiﬁed in the RNA seq data, suggesting that the
tissue composition is mainly spinal cord. Hundreds of genes were
differentially regulated at 4 days post injury after miR-200a
inhibition compared to uninjured spinal cords (Table S1, Sup-
plementary Figure 3). Further analysis identiﬁed a handful of
genes known to be involved in reactive gliosis and glial scar
formation to be upregulated after inhibitor treatment, this we
conﬁrmed by qRT-PCR (Fig. 6b). Although the axolotl is a very
powerful research organism for studying regeneration, one lim-
itation still faced is the paucity of antibodies available speciﬁc to
axolotl proteins. However we could conﬁrm upregulation of some
of these genes at the mRNA level and see that they are expressed
in the glial cells adjacent to the injury site (Supplementary Fig-
ure 4). This data suggests that miR-200a is necessary to inhibit a
reactive gliosis circuitry from being activated after injury in
axolotl glial cells. In addition many of the genes found to be
differentially regulated during axolotl regeneration are genes
known to be important for spinal cord regeneration in ﬁsh and
other salamanders, suggesting a high degree of pathway con-
servation across species (Fig. 6)12,106–109. Interestingly, bioinfor-
matics analysis of the promoter regions of GFAP, Vimentin,
CSPG4 and CSPG5 using PROMO revealed multiple DNA
binding motifs for c-Fos, JunB and c-Jun, further supporting our
hypothesis that these factors could differentially regulate these
gene promoters during spinal cord regeneration (Supplementary
Figure 5).
Collectively, our work identiﬁes an important role for the
c-Fos:JunB heterodimer in activation of glial cells after spinal
cord injury to guide them to a regenerative state (Fig. 7). It
also identiﬁes an important molecular difference in a highly
conserved early response heterodimer in axolotls versus mam-
malian glial cells.
Methods
Animal handling, spinal cord injury and electroporation. All axolotls used in
these experiments were obtained from the Genetic Stock Center at the University of
Kentucky, bred at the University of Minnesota in accordance with IACUC protocol
No. 1710-35242A, or bred the Marine Biological Laboratory in compliance with
IACUC protocol number 18–49. All animal experiments were carried out in
compliance of USA animal welfare legislation. In all experiments the white strain of
Ambystoma mexicanum was used, all animals were 3–5 cms in length, a size at
which sex is not yet identiﬁable. Prior to all in vivo experiments animals (3–5 cm)
were anesthetized in 0.01% p-amino benzocaine (Sigma). Spinal cord ablations
were performed as previously described10,11. Brieﬂy, animals were anesthetized, the
skin and muscle above the spinal cord was peeled back using ﬁne forceps. Then a
piece of spinal cord, approximately the length of 1 muscle bundle, was transected
using small surgical scissors and gently removed. The skin ﬂap was replaced and
the animal was placed back into water to recover. For miR-200a inhibition
experiments, a chemically synthesized miR-200a or scrambled control inhibitor
(Dharmacon) were diluted to 20uM in PBS+ 1% Fast Green and microinjected
into the central canal of axolotls and were electroporated (5 square pulses, 50 ms,
50 V using an ECM830 Electro Square Porator BTM Harvard Apparatus) twice.
For overexpression experiments plasmids were diluted to 1–1.5 μg/μL in PBS+ 1%
Fast Green and animals were injected and electroporated as described above.
Immunoﬂuorescence. Tissue was harvested at the indicated time points and were
ﬁxed and processed for cryosectioning as previously described11.
For IHC, tails were sectioned at 20 μm using a Leica CM1850 cryostat. The
following primary antibodies were used for immunoﬂuorescent staining: c-Jun
(1:100, Cell Signaling), GFAP (1:100 Chemicon) or NeuN (1:100 Chemicon). All
sections were incubated in boiling 10 mM sodium citrate buffer+ 0.1% Tween
20 for 10 min prior to standard IHC protocol11. After secondary incubation the
slides were washed four times with PBSTx and embedded with 80% glycerol and
imaged using an inverted Leica DMI 6000B ﬂuorescent microscope.
Double positive GFAP+/cJun+ glial cells were quantiﬁed by counting the
number of glial cells expressing nuclear c-Jun that were also GFAP
immunoreactive. The percent double positive glial cell was calculated by the
number of GFAP+/cJun+ cells divided by the total number of GFAP+ glial cells.
Whole mount immunoﬂuorescence. Tails were harvested at 7 days post injury
and ﬁxed in 4% PFA. Whole mount β-III tubulin staining was performed as
previously described10,11 with one minor modiﬁcation. Secondary antibody (anti-
mouse 568 Invitrogen) staining was left overnight at 4 °C. After washing off excess
secondary, tails were gradually stepped into methanol by incubating with 25%,
50%, 75% then 100% methanol:PBSTx solution and then stored at –20 °C until
imaged. Prior to imaging, the tails were cleared using 1:2 solution of benzyl alcohol
and benzyl benzoate (Sigma) for 20 min and mounted onto a cover slip using
BABB as the mounting medium.
EdU staining. Control and miR-200a inhibitor electroporated animals were
injected with 5-ethynyl-2´-deoxyuridine (EdU) at a ﬁnal concentration of 0.3 μg/
μL. For glial cell proliferation, EdU was injected 3 days post injury and tissue was
harvested 24 h later. For neuronal differentiation, EdU was injected on the day of
injury and tissue was harvested 5 days later. Samples were prepared for EdU and
antibody staining as described above. EdU staining was carried out on frozen cross-
sections. EdU incorporation was detected using the Click-iT EdU Alexa Fluor 555
Imaging kit (Molecular Probes) prior to GFAP or NeuN staining.
Acid fuschin orange G staining. AFOG staining was performed on cross-sections
and parafﬁn sections as described previously11.
qRT-PCR. The spinal cords 500 μm rostral and 300 μm caudal to the lesion from
7–10 control or miR-200a inhibitor electroporated animals were microdissected
and pooled for each biological replicate. Total RNA was isolated using Trizol
according to the manufacturer. Subsequent cDNA was synthesized from 1 μg of
DNaseI (NEB) treated RNA using either High Capacity cDNA Reverse Tran-
scription kit (Applied Biosystems) or miScript II RT kit (Qiagen). The qRT-PCR
was carried out using LightCycler 480 SYBR Green I Master (Roche). MicroRNA
qRT-PCR was carried out with custom designed primers to conserved miRNAs
(Qiagen) and custom primers from IDT were used to quantify axolotl mRNAs
(5′–3′):
18S_F: CGGCTTAATTTGACTCAACACG
18S_R: TTAGCATGCCAGAGTCTCGTTC
cFos_F: TCCCTCTACACCTCCGAC
cFos_R: AAAGCGTCCGATTCAGGG
cJun_F: CTCTGCCCCAAGAATGTGAC
cJun_R: GAAGTTGCTGAGGTTGGCAT
JunB_F: CTCCTTCCTGCCTGGCTATG
JunB_R: ACTGTCCGAGCCAAAGTAGC
GFAP_F: ACAGAGCCTAAACAGTGATG
GFAP_R: GTCTTTAAGGTTCCGGATGT
Vimentin_F: AACACTCTCCAGTCTTTCAG
Vimentin_R: TCTTCGTCGTGTAGTTTCTT
CSPG4_F: ATTCCATTACCCCACCTAGT
CSPG4_R: AGCTGCCCCTCATTAATATG
CSPG5_F: CATGATGACCGTTTTCTTCG
CSPG5_R: GATGGTGGACAGAGAAAAGT
Col4a1_F: GTGGCTATCTCTCTGGATTG
Col4a1_R: CCATGGCACTCAATAAATGG
microRNA and mRNA in situ hybridization. Samples were ﬁxed in fresh 4% PFA
at 4 °C overnight. The following day they were washed 3 times for 10 min in PBS.
Then they were gradually stepped into 100% methanol and stored at –20 °C.
The samples were gradually stepped back into PBS and processed for cryo-
sectioning, as described above. To remove OCT after sectioning the slides were
washed 3 times for 10 min in PBSTw before being incubated with Protinase K
(2 μg/μL) for 10 min. The slides were rinsed once and then washed for 2 min in a
glycine solution (2 mg/mL). Then slides were rinsed 3 times with PBSTw and
incubated in a 1:1 solution of hybridization buffer:PBSTw for 10 min. Following
that the slides were incubated in hybridization buffer plus yeast tRNA extract for
3 h at room temperature. After the pre-hybridization step miR-200a LNA probe
(Exicon) was added to the slides at a ﬁnal concentration of 40 nM. Slides were
hybridized over night at 53 °C. The following day slides were washed in 5x SSC
buffer for 10 min then 0.2% SSC buffer for one hour. Both washes were carried out
at 60 °C. The slides were then stepped back into PBSTw and washed one ﬁnal time
in PBSTw for 10’. Then slides were blocked in PBSTw+ 2% BSA+ 2% sheep
serum for 1 h at room temperature and anti-DIG antibody (Roche) was diluted
1:1000 in blocking buffer for 2 h. Slides were then rinsed 2 times in PBSTw and
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washed 3 times for 10 min in PBSTw before being incubated in fresh AP buffer
3 times for 5 min. After the ﬁnal wash BM Purple was added and slides were
checked often for color development. Finally, upon completion of the reaction
sections were ﬁxed in 4% PFA for 10 min, rinsed 3 times in PBSTw then embedded
with 80% glycerol and imaged using an Olympus BX40 inverted microscope.
JunB probe synthesis. Axolotl speciﬁc JunB probes were created by PCR ampli-
ﬁcation with the addition of the T7 and Sp6 promoter into the PCR primers:
T7 JunB ISH For 5′-
AGAtaatacgactcactatagggAATGTGCCGTGCAGCGGATA-3′
Sp6 JunB ISH Rev 5′-
AGAtatttaggtgacactatagAAGAGGTAGAGGGAGCCCAGTC-3′
The resulting PCR product was used to synthesize in situ probe by the addition
of DIG-labeled UTP (Roche) plus the appropriate RNA Polymyerase T7 or Sp6
(NEB). Probes were puriﬁed with RNA Clean Up kit (Qiagen) and resuspended in
100 μL of hybridization buffer.
Primers for other genes (5′–3′):
Vimentin ISH Forward ACAAGTCAAAGTTCGCTGAT
Vimentin ISH Reverse CCATCTCTGGTCTCAACAGT
NG2 ISH Forward CTTACTGTCGACGAGGAGAC
NG2 ISH Reverse TCGGGCTGTTGTACTATCTT
Galectin-1 Forward TAGGGGTCATGTGACTTTTC
Galectin-1 Reverse AGGCAACTAGTCCAGTTTGA
The PCR fragment was subcloned into pGemTEasy vector. The plasmid was
then linearized and used to synthesize in situ probe by the addition of DIG-labeled
UTP (Roche) plus the appropriate RNA Polymyerase T7 or Sp6 (NEB). Probes
were puriﬁed with RNA Clean Up kit (Qiagen) and resuspended in 100 μL of
hybridization buffer.
mRNA in situ hybridization. Samples were prepared as described above. After
sectioning slides were incubated in 70 °C PBS for 15 min to remove OCT. Then the
slides were incubated in 1:1 PBS:EtOH for 5 min before being washed in 100%
EtOH for 5 min. Then the slides were incubated in Xylene for 30 min before being
washed twice in 100% EtOH. After washing, the slides were transferred to 100%
MeOH for 5 min and gradually stepped into PBST. Then slides were incubated in
1:1 PBST:Hyb for 10 min and pre-hybridized for 30 min. JunB probes were diluted
into hybridization buffer and slides were allowed to hybridize overnight at 55 °C.
The following day the slides were washed 3 times in Wash Buffer (50% Formamide,
5x SSC and 0.1% Tween) for 30 min each, once in 1:1 Wash Buffer:PBST for
30 min and once in PBST at 55 °C. Slides were rinsed in room temperature PBST
3 times for 5 min each before blocking buffer was added (2% goat serum, 2% BST
in PBSTx) for 1 h. Anti-DIG FAB (Roche) was diluted 1:1000 in blocking buffer
and slides were incubated for at least 1 h. Slides were washed 3 times for 10 min
each before addition of fresh AP Buffer for at least 10 min. Finally slides were
incublated in BM Purple (Roche) until colored reaction was observed. The reaction
was stopped by several quick rinses in PBS and slides were ﬁxed in 4% PFA for
10 min. Slides were mounted in 80% glycerol and images were taken with a BX40
Olympus Inverted microscope.
Cloning and plasmids. The full-length axolotl JunB and axolotl cJun 3′-UTR were
cloned using rapid ampliﬁcation of cDNA ends (Clontech) as per the manu-
facturer’s instructions.
JunB 5′ GSP 1: GCTGCACCACTGTCCGAGCCAAAGT-3′
JunB 5′ NGSP 1: TGGGTCAGTGAGGTTAAGGGCCAAGC-3′
JunB 3′ GSP 1: CCTCAACCCCACTACTCCACCTCGG-5′
JunB 3′ NGSP 1: GACCAAGAGCGCATTAAGGTGGAGCG-3′
cJun 3′ GSP 1: GAACCGCATCGCCGCCTCCAAGTG-3′
cJun 3′ NGSP 1: GCAGAACTCGGAGCTGGCTTCCACG-3′
The coding sequences of axolotl c-Fos and c-Jun were cloned based on Trinity
assembled RNA sequencing contigs from axolotl-omics.org. The coding sequence
of axolotl JunB was ampliﬁed using primers based on the full-length transcript
from our RACE experiments. PCR fragments for c-Fos, c-Jun and JunB were
digested with the indicated restriction enzymes and ligated into the pCMV:GFP
expression vector (Clontech). Restriction fragments were ligated together using
T4 DNA Ligase (NEB) overnight at 4 °C and heat shock transformed into DH5α
competent E. coli (Promega)
cFos For Axolomics NheI ATTGCTAGCACCATGTTCCAGGGCTTCTCGGG
cFos Rev Axolomics SacII ATCCCGCGGCAGAGCAAGCAAAGTAGGCG
cJun For XhoI ATTCTCGAGACCATGGAGCCTACGTTCTACG
cJun Rev SalI ATTGTCGACACATGAACGTCTGCAGCTGCTG
JunB For NheI ATTGCTAGCACCATGTGCACCAAGATGGACG
JunB Rev SacII ATTCCGCGGAAAGGGCTGCATCTTGGCA
Sequences for the human versions of c-Fos (#70382), c-Jun (#70398) and JunB
(#29687) were cloned from the indicated Addgene plasmids using the following
primers (5′–3′) and subcloned into pCMV:GFP (Clontech):
cFos FL Hs For SalI TATGTCGACACCATGACTGCAAAGATGGAAACGA
cFos FL Hs Rev BamHI ACTGGATCCAAATGTTTGCAACTGCTGCGTTAG
cJun FL Hs For SalI TATGTCGACACCATGACTGCAAAGATGGAAACGA
cJun FL Hs Rev BamHI ACTGGATCCAAATGTTTGCAACTGCTGCGTTAG
JunB FL Hs For SalI TATGTCGACACCATGTGCACTAAAATGGAACAGCC
JunB FL Hs Rev BamHI ACTGGATCCGAAGGCGTGTCCCTTGAC
For 3’ UTR luciferase experiments, primers were designed to amplify the cJun
3’ UTR based off our RACE sequences. All the 3’ UTRs were ampliﬁed with a
5′ SpeI and 3′ HindIII restriction site.
cJun 3′-UTR Luc For ATAACTAGTGGAGGGAAGCGCGG
cJun 3′-UTR Luc Rev AGCAAGCTTGTTTGTAGTTTAGTTTGTAATAC
cJun 3′-UTR SDM Rev2 GATCTGTTTGAATTCACCAAGAACTGCAT
cJun 3′-UTR SDM For 2 GTTCTTGGTGAATTCAAACAGATCTCGC
The PCR fragments and pMiR Report (Life Technologies) were digested with
SpeI and HindIII (NEB) and the fragments were ligated over night at 4 °C with
T4 DNA Ligase (NEB) and heat shock transformed into DH5α competent E. coli
(Promega).
Cloning of the axolotl GFAP promoter. Genomic DNA was isolated from tails
of 2–3 cm axolotls using Jetﬂex Genomic DNA Puriﬁcation kit (Invitrogen).
Following puriﬁcation of genomic DNA, we used GenomeWalker Universal kit
(Clontech) to determine the DNA sequence upstream of the GFAP transcription
start site. Two rounds of “walking” were performed using the below primers
(5′–3′):
GFAP Promoter GSP1 TTTCCCAACTTCAGCCTCGCAAGACTC
GFAP Promoter NGSP1 ACTTTTGAGGAGGGCCGTTAGAGAAC
GFAP Promoter GSP2 TTCACTGTGGCGTCATGTGGATCGGTAACC
GFAP Promoter NGSP2 TTCCAGCACACTCTGCGTCCCTTTGTTTGC
Distinct PCR bands TA cloned into pGEM-T EZ (Promega) and inserts were
sequenced. Based on this analysis we designed primers to amplify ~1.3 kb of the
axolotl GFAP promoter using Phusion High Fidelity polymerase (NEB) (5′–3′):
pAxGFAP For 2 XhoI ATACTCGAGTACCTGGCATTGACATTATCTGGTC
pAxGFAP Rev1 HindIII
ATAAAGCTTTTTCAGAGTTTCCCAACTTCAGCCT
The resulting PCR product was ligated as a XhoI and HindIII fragment into
pGL3 Enhancer luciferase reporter plasmid (Invitrogen).
Luciferase experiments. 3’ UTR luciferase experiments
B35 neural progenitor cells were plated in a 96 well plate (Celltreat Scientiﬁc
Products) at a concentration of 1.0 × 105 cells/mL and allowed to adhere overnight.
The next day cells were co-transfected with axolotl c-Jun 3’ UTR luciferase
reporter, β-Galatosidase internal control and 100 nM of miR-200a or control
mimic (Qiagen) Lipofectamine 3000 (Invitrogen). After 48 h luciferase activity
was determined using Dual Light Reporter system (Thermo) according to the
manufacturers protocol.
GFAP promoter luciferase assays. B35, neural progenitor cells were co-
transfected with pGFAP: Luciferase, β-Galatosidase internal control, axolotl c-Jun
and/or JunB subcloned into pCMV:GFP plasmid (Clontech) with Lipofectamine
3000. After 48 h luciferase activity was determined using Dual Light Reporter
system (Thermo) according to the manufacturer’s protocol.
The similar experiment was carried out using the axolotl GFAP promoter.
BioID experiments. The axolotl JunB ORF was subcloned into the EcoRV and
BamHI sites of BioID Myc tag vector (Addgene #35700). (5′–3′):
JunB_BioID_Myc_For ATAGATATCTACCATGTGCACCAAGATGGAG
JunB_BioID_Myc_Rev AGGGGATCCTCAAAAGGGCTGCATCTTG
A total of 293 cells were plated in 24-well plate (1 × 105 cells per well) and
transfected with either empty BioID+ c-Fos, JunB-BioID alone or JunB-BioID+
cFos. After 24 h biotin (50 μM) was added to the cell culture media and allowed
to incubate for an additional 24 h. Finally, cells were lysed in boiling RIPA buffer
and sonicated to lyse cells and sheer DNA. Then 50 μL of pre-washed Dynabeads
MyOne Streptavidin T1 (ThermoFischer) was added per lysate and allowed to
incubate at 4 °C. The following day the beads were washed 4 times in RIPA buffer
and bound proteins were released from beads by addition of 25 μL of LSB, an
excess of biotin and incubated at 95 °C for 5 min.
Western blot analysis. Western blot was performed as previously described11.
Anti-c-Fos antibody (Millipore) was diluted 1:500 in 5% milk in Tris Buffered
Saline+ 0.1% Tween and incubated at 4 °C overnight. Anti-Rabbit DyLight 68o
(Cell Signaling) was diluted 1:10000 in blocking buffer for 1 h. Following 4 TBST
washes signal was detected using a Licor Odyssey CLx.
RNA sequencing sample preparation. For RNA sequencing animals (3–5 cm)
were electroporated with miR-200a inhibitor or control inhibitor and a spinal cord
trasection was performed, as described above. Animals were electroporated on the
day of injury and 2 days post injury. Spinal cords 500 μm rostral and 300 μm
caudal to the lesion were microdissected at 4 days post injury for RNA extraction
using TRIzol (Thermo Scientiﬁc) according to the maufacturers protocol. Each
sample (Uninjured, 4 days post inury Control and 4 ddays post injury Inhibitor)
consisted of 6 pooled spinal cords and samples were submitted in biological
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triplicates. Library preparation and RNA sequencing was performed by the
Genomics Center at the University of Minnesota.
RNA-seq data analysis. RNA-seq data were comprised of 2 × 126 bp paired-end
reads. The RNA-seq reads from all samples were combined and then assembled by
using Trinity110 (v2.3.2) with default parameters. We used cd-hit-est (v4.6)111 with
parameter “-c 1” to remove shorter contigs with 100% identity with aligned longer
contigs. These non-redundant contigs were mapped to Ensembl human proteins
(v85) by BLASTX (v2.2.18). Contigs were assigned to human proteins by taking the
best BLASTX hit with E-value < 10-5.
We used Bowtie (v0.12.1)112 to map the reads against all non-redundant
contigs. Quantiﬁcation of each contig was performed by RSEM v1.1.6113. RSEM
employs an expectation maximization algorithm, so that for reads that match to
multiple contigs, RSEM assigns a fraction of each read to each contig based on
estimated abundances of contigs based on unique reads113.
For each sample, the expected fragment counts for each contig (as computed by
RSEM), were then converted to comparative transcript counts by summing the
fragment counts of contigs mapped to the same transcript. Similarly, gene-level
counts were obtained by summing the fragment counts of transcripts that were
annotated with the same gene symbol. Relative abundances, in terms of transcripts
per million (TPM), for genes were computed by ﬁrst normalizing each gene’s
fragment count by the sum of the effective lengths (weighted average of contigs’
length based on contigs’ abundance) of the contigs mapped to that gene and then
scaling the resulting values such that they summed to one million over all genes, as
described previously114. To identify differentially expressed genes, the normalized
counts from RSEM were imported into DESeq2 (version 1.16.1)115 as integers to
determine moderated estimates of Log2 fold changes and Benjamini-Hochberg
adjusted p-values between conditions.
Statistical analyses. All results are presented as mean+ /− s.t.d. unless otherwise
stated. Analyses were performed using Microsoft Excel or GraphPad Prism. Data
set means were compared using ANOVA for three or more tests with a Dunnett’s
or Tukey’s post hoc analysis. When two groups were compared a Students t-test
was used. Differences between groups was considered signiﬁcant at three different
levels (p values of *p < 0.05, **p < 0.01 and ***p < 0.001) and are indicated in the
ﬁgure legends.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The authors declare that all data supporting the ﬁndings of this study are available within
the article and its Supplementary Information ﬁles or from the corresponding author
upon reasonable request. The RNA seq data has been deposited in the public GEO
database with the accession number GSE122939.
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